Cetuximab Sensitivity Associated with Oxaliplatin Resistance in Colorectal Cancer | Anticancer Research
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress | Cell Death & Disease
Combination effect of niclosamide and oxaliplatin on colorectal cancer... | Download Scientific Diagram
Figures and data in Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization | eLife
Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines | Scientific Reports
DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer | Cell Death & Disease
H19 promotes the stemness and oxaliplatin resistance of colorectal... | Download Scientific Diagram
Frontiers | Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
MiR-135b-5p promotes oxaliplatin resistance in colorectal cancer cell... | Download Scientific Diagram
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan - ScienceDirect
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | PLOS ONE
Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS
Oxaliplatino - Wikipedia
Cancers | Free Full-Text | Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells
miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer: Molecular Therapy - Oncolytics
Frontiers | A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells | Oncotarget
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer | NEJM
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2: Molecular Therapy - Oncolytics
Benefits & Risks of Treatment | Metastatic Colorectal Cancer (mCRC)| Avastin® (bevacizumab)
Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivo | SpringerLink
